TWO SIGMA INVESTMENTS, LP - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$364,554
-48.2%
116,100
-14.8%
0.00%
-50.0%
Q2 2023$703,308
-58.7%
136,300
-57.9%
0.00%
-60.0%
Q1 2023$1,704,444
+220.8%
323,424
+71.0%
0.01%
+150.0%
Q4 2022$531,329
-35.3%
189,085
-4.4%
0.00%
-33.3%
Q3 2022$821,000
-65.7%
197,760
-59.1%
0.00%
-57.1%
Q1 2022$2,392,000
-27.0%
483,284
+2.9%
0.01%0.0%
Q4 2021$3,275,000
-63.4%
469,866
-47.5%
0.01%
-65.0%
Q3 2021$8,954,000
-39.1%
895,400
-13.6%
0.02%
-39.4%
Q2 2021$14,691,000
-23.4%
1,036,045
-11.3%
0.03%
-34.0%
Q1 2021$19,174,000
+0.7%
1,168,458
+27.0%
0.05%
-9.1%
Q4 2020$19,050,000
+657.8%
920,295
+178.6%
0.06%
+511.1%
Q3 2020$2,514,000
+59.7%
330,300
+74.8%
0.01%
+12.5%
Q2 2020$1,574,000
+1200.8%
188,915
+675.5%
0.01%
+700.0%
Q1 2020$121,000
-0.8%
24,361
-20.7%
0.00%
Q1 2019$122,000
-56.3%
30,737
-56.2%
0.00%
-100.0%
Q4 2018$279,000
+113.0%
70,181
+269.5%
0.00%
Q3 2018$131,00018,9950.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders